Patient Guide: A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 13 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06839872
Status: WITHDRAWN
Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase: PHASE2

Find a Study Location Near You

This study is available at 13 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Saint Petersburg, Florida
  • Ames, Iowa
  • Baltimore, Maryland
  • • And 10 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily